Which boxed warning is associated with clindamycin?

Which boxed warning is associated with clindamycin?

• A. Clostridioides difficile infection
• B. QT prolongation
• C. Serotonin syndrome
• D. Hepatotoxicity

Answer: (A)

The boxed warning for clindamycin focuses on Clostridioides difficile infection. Antibiotics can disrupt the normal gut bacteria, allowing C. difficile to overgrow and produce toxins that cause ranging from mild diarrhea to severe, life-threatening colitis. This risk can persist even after stopping the drug, so patients should monitor for persistent or worsening diarrhea and seek prompt medical care if it occurs. Discontinuing the antibiotic and starting appropriate therapy for CDAD are essential if suspected. QT prolongation is not typically linked to clindamycin; that risk is more associated with certain macrolides and other drugs. Serotonin syndrome relates to drugs that affect serotonin systems (like linezolid or SSRIs), not clindamycin. Hepatotoxicity can occur with many meds, but it isn’t the boxed warning specific to clindamycin.

The boxed warning for clindamycin focuses on Clostridioides difficile infection. Antibiotics can disrupt the normal gut bacteria, allowing C. difficile to overgrow and produce toxins that cause ranging from mild diarrhea to severe, life-threatening colitis. This risk can persist even after stopping the drug, so patients should monitor for persistent or worsening diarrhea and seek prompt medical care if it occurs. Discontinuing the antibiotic and starting appropriate therapy for CDAD are essential if suspected.

QT prolongation is not typically linked to clindamycin; that risk is more associated with certain macrolides and other drugs. Serotonin syndrome relates to drugs that affect serotonin systems (like linezolid or SSRIs), not clindamycin. Hepatotoxicity can occur with many meds, but it isn’t the boxed warning specific to clindamycin.